Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APMD

Apnimed Inc

27.00

Aug 07 • 3:59 PM ET -0.88 (-3.16%)

27.24

Aftermarket • 7:53 PM ET +0.24 (0.89%)

Healthcare Biotechnology USA Small NASD

Peers: OLMA CGEM ANRO IVA SVRA JANX REPL LXRX AXSM JAZZ

| Held by: JDOC

Scroll to Statements

Index	-
Market Cap	1.12B
Enterprise Value	1.36B
Income	-
Sales	-
Book/sh	-7.64
Cash/sh	1.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jul 31, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	23.97
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.82
Current Ratio	1.82
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	-69.75% -
Sales past 3/5Y	237.57% -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	1.91%
Insider Trans	69.15%
Inst Own	-
Inst Trans	17.54%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	3.12%
SMA50	3.12%
SMA200	3.12%
Trades

Shs Outstand	39.82M
Shs Float	39.07M
Short Float	-
Short Ratio	-
Short Interest	-
52W High	29.15 -7.38%
52W Low	16.12 67.49%
Volatility	16.39% -
ATR (14)	5.45
RSI (14)	-
Beta	-
Rel Volume	0.15
Avg Volume	1.05M
Volume	160,890

Perf Week	8.00%
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	22.73%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	27.88
Price	27.00
Change %	-3.16%

Aug-03-26 04:35PM

Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

(GlobeNewswire)

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Kevin Robert Lind

M.P.H.Dr. Lawrence G. Miller M.D.

Co-Founder & Chief Scientific OfficerDr. Luigi Taranto Montemurro M.D.

Chief Financial OfficerMr. Michael B. Kelly

Senior Manager of AdministrationMs. Leila Sylvain

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Morningside Venture Investment	10% Owner	Aug 03 '26	Buy	16.00	312,500	5,000,000	7,152,713	Aug 05 04:18 PM
SEKHRI PAUL J	Director	Aug 03 '26	Buy	16.00	12,500	200,000	12,500	Aug 03 04:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APMD

Apnimed Inc

Upgrade your Finviz experience